A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and Pleasure

NCT06635135 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

47

Enrollment

INDUSTRY

Sponsor class

Stopped Early study termination due to insufficient efficacy.

Conditions

Depressive Disorder, Major
Anhedonia

Interventions

DRUG: Aticaprant
OTHER: Placebo

Sponsor

Janssen Research & Development, LLC